Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma
- PMID:27690671
- DOI: 10.1080/17425247.2017.1242574
Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma
Abstract
Very few successful interventions have been possible in glioma therapy owing to its aggressive nature as well as its hindrance of targeted therapy together with the limited access afforded by the blood-brain barrier (BBB). With the advent of nanotechnology based delivery vehicles such as micelles, dendrimers, polymer-based nanoparticles and nanogels, the breach of the BBB has been facilitated. However, there remains the issue of targeted therapy for glioma cells. Peptide-mediated surface modification of nanocarriers serves this purpose, extending the ability to target glioma further than the enhanced permeability and retention effect. Areas covered: Here we have tried to re-establish the significance of peptides that could be used in various ways for treating glioma. Peptide-embellished nanocarriers used to deliver anticancer drugs; nucleic acids (siRNA, miRNA); micelles or dendrimers grafted with immunogenic glioma-derived peptides used for stimulating active immunity in vaccine therapy, glioma targets for cell penetrating peptides and homing to specific receptors are reviewed. Expert opinion: Peptides have multifunctional potential in targeting, BBB and cell penetration, and can serve as antagonists of various ligands and agonists of particular over-expressed receptors as discussed in this review. Using peptides in targeted personalized therapy would be one step forward and may offer new avenues for glioma therapeutics.
Keywords: BBB; Glioma; cell penetrating and homing peptides; nanocarriers for glioma; peptide glioma; peptide vaccines.
Similar articles
- Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.Chen Y, Zhang M, Jin H, Li D, Xu F, Wu A, Wang J, Huang Y.Chen Y, et al.Theranostics. 2017 Aug 15;7(14):3489-3503. doi: 10.7150/thno.20578. eCollection 2017.Theranostics. 2017.PMID:28912890Free PMC article.
- Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.Zhu Y, Jiang Y, Meng F, Deng C, Cheng R, Zhang J, Feijen J, Zhong Z.Zhu Y, et al.J Control Release. 2018 May 28;278:1-8. doi: 10.1016/j.jconrel.2018.03.025. Epub 2018 Mar 27.J Control Release. 2018.PMID:29596873
- Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.Wei X, Gao J, Zhan C, Xie C, Chai Z, Ran D, Ying M, Zheng P, Lu W.Wei X, et al.J Control Release. 2015 Nov 28;218:13-21. doi: 10.1016/j.jconrel.2015.09.059. Epub 2015 Sep 30.J Control Release. 2015.PMID:26428462
- Blood-brain barrier-crossing dendrimers for glioma theranostics.Wang J, Wang Z, Zhang G, Rodrigues J, Tomás H, Shi X, Shen M.Wang J, et al.Biomater Sci. 2024 Mar 12;12(6):1346-1356. doi: 10.1039/d4bm00043a.Biomater Sci. 2024.PMID:38362780Review.
- Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.Zhang F, Xu CL, Liu CM.Zhang F, et al.Drug Des Devel Ther. 2015 Apr 9;9:2089-100. doi: 10.2147/DDDT.S79592. eCollection 2015.Drug Des Devel Ther. 2015.PMID:25926719Free PMC article.Review.
Cited by
- The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.Lu L, Chen H, Hao D, Zhang X, Wang F.Lu L, et al.Asian J Pharm Sci. 2019 Nov;14(6):595-608. doi: 10.1016/j.ajps.2019.04.004. Epub 2019 May 25.Asian J Pharm Sci. 2019.PMID:32104486Free PMC article.Review.
- Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective.Milewska S, Sadowska A, Stefaniuk N, Misztalewska-Turkowicz I, Wilczewska AZ, Car H, Niemirowicz-Laskowska K.Milewska S, et al.Int J Mol Sci. 2024 Jun 5;25(11):6219. doi: 10.3390/ijms25116219.Int J Mol Sci. 2024.PMID:38892406Free PMC article.Review.
- Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.Tincu Iurciuc CE, Andrițoiu CV, Popa M, Ochiuz L.Tincu Iurciuc CE, et al.Polymers (Basel). 2023 Oct 2;15(19):3969. doi: 10.3390/polym15193969.Polymers (Basel). 2023.PMID:37836018Free PMC article.Review.
- How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature.Yang Y, Cheng N, Luo Q, Shao N, Ma X, Chen J, Luo L, Xiao Z.Yang Y, et al.Int J Nanomedicine. 2023 Jul 3;18:3663-3694. doi: 10.2147/IJN.S414736. eCollection 2023.Int J Nanomedicine. 2023.PMID:37427368Free PMC article.Review.
- Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS.Mitusova K, et al.J Nanobiotechnology. 2022 Sep 15;20(1):412. doi: 10.1186/s12951-022-01610-7.J Nanobiotechnology. 2022.PMID:36109754Free PMC article.Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical